pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 7·1 min read
save

STAT+ warns that employer-sponsored health insurance is deteriorating, leaving workers and businesses exposed

Jul 7, 2026·read at STAT ↗Negative

Bob Herman's latest STAT+ newsletter introduces a new series called Out of Pocket, Out of Reach, which will examine how the employer-based health-insurance system is falling apart.

The article notes that most U.S. workers receive health coverage through their jobs, but rising costs and stagnant wages are eroding the value of that benefit. It suggests that earnings have quietly suffered over time as insurance premiums increase.

Herman calls the situation a crisis, saying it is arguably never been worse and is unlikely to improve without major changes. He invites readers to share personal experiences about how job-based coverage affects them.

For pharmaceutical companies and investors, the weakening of employer coverage could influence drug pricing negotiations and market access, making the trend an important factor to watch.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: America’s employer health insurance is decaying”

read at STAT ↗
523 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
Major Depression

related stories

  • Sep 29Researchers slow neurodegeneration in mice by barring T cells from the brainSTAT
  • Sep 29Opinion: Child health is the national security crisis we keep ignoringSTAT
  • Sep 14Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’BioSpace
  • Sep 14Psychedelic therapies ride wave of public favor into FDA hearingBioSpace
  • Sep 9Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'Fierce Biotech